Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cannabisblüten (cannabis flowers) refers to the standardized, dried inflorescences of the *Cannabis sativa* L. plant, produced by Bedrocan for medicinal use. These botanical products contain a complex profile of cannabinoids, primarily delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), along with various terpenes. They are used as an active pharmaceutical ingredient (API) or directly by patients via inhalation (vaporization) or oral administration (tea). In Germany, they are regulated under the German Pharmacopoeia (DAB) and are approved for the treatment of chronic pain, spasticity associated with multiple sclerosis, chemotherapy-induced nausea and vomiting, and other conditions where standard treatments are insufficient.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cannabis flowers.